Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Tamir Biotechnology, Inc. | ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Tamir Biotechnology, Inc. | ex31-2.htm |
| EX-23.2 - EXHIBIT 23.2 - Tamir Biotechnology, Inc. | ex23-2.htm |
| EX-23.1 - EXHIBIT 23.1 - Tamir Biotechnology, Inc. | ex23-1.htm |
| EX-10.57 - EXHIBIT 10.57 - Tamir Biotechnology, Inc. | ex10-57.htm |
| EX-10.56 - EXHIBIT 10.56 - Tamir Biotechnology, Inc. | ex10-56.htm |
| 10-K - ANNUAL REPORT - Tamir Biotechnology, Inc. | tamir_10k-073110.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of Tamir Biotechnology, Inc. (the “Company”) on Form 10-K for the fiscal year ended July 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Charles Muniz, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
October 29, 2010
| /s/ CHARLES MUNIZ | ||
| Charles Muniz | ||
|
Chief Executive Officer and Chief Financial Officer (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer of Tamir Biotechnology, Inc.)
|
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Tamir Biotechnology, Inc. and will be furnished to the Securities and Exchange Commission or its staff upon request.